Skip to Content
Merck
All Photos(2)

Documents

GF62158596

Lithium

foil, not light tested, 38x200mm, thickness 0.20mm, as rolled, 99.9%

Synonym(s):

Lithium, LI000220

Sign Into View Organizational & Contract Pricing
All Photos(2)

About This Item

Linear Formula:
Li
CAS Number:
7439-93-2
Molecular Weight:
6.94
MDL number:
MFCD00134051
UNSPSC Code:
12141803
PubChem Substance ID:
329809388
NACRES:
NA.23

Assay

99.9%

form

foil

manufacturer/tradename

Goodfellow 621-585-96

resistivity

9.446 μΩ-cm, 20°C

size × thickness

38x200 mm × 0.20 mm

bp

1342 °C (lit.)

mp

180 °C (lit.)

density

0.534 g/mL at 25 °C (lit.)

SMILES string

[Li]

InChI

1S/Li

InChI key

WHXSMMKQMYFTQS-UHFFFAOYSA-N

Looking for similar products? Visit Product Comparison Guide

General description

For updated SDS information please visit www.goodfellow.com.

Legal Information

Product of Goodfellow

Storage Class Code

4.3 - Hazardous materials which set free flammable gases upon contact with water

WGK

WGK 1

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Mustafa Khasraw et al.
BMC medicine, 10, 131-131 (2012-11-06)
Neurocognitive impairment is being increasingly recognized as an important issue in patients with cancer who develop cognitive difficulties either as part of direct or indirect involvement of the nervous system or as a consequence of either chemotherapy-related or radiotherapy-related complications.
Annemiek Dols et al.
International clinical psychopharmacology, 28(6), 287-296 (2013-07-23)
Side effects are among the most frequent reasons preventing patients from taking their medication. Although the management of side effects is an important issue in clinical practice, particularly in patients with physical comorbidities, research on clinical management of side effects
Susan W Lehmann et al.
Journal of affective disorders, 146(2), 151-157 (2012-09-19)
Lithium has been reported to induce hypercalcemia and hyperparathyroidism, yet few studies have examined the impact on older patients. We therefore undertook this review and report our findings. We undertook a systematic review of articles on lithium-associated hypercalcemia and/or hyperparathyroidism
Rebecca F McKnight et al.
Lancet (London, England), 379(9817), 721-728 (2012-01-24)
Lithium is a widely used and effective treatment for mood disorders. There has been concern about its safety but no adequate synthesis of the evidence for adverse effects. We aimed to undertake a clinically informative, systematic toxicity profile of lithium.
Xianglong Li et al.
Nanoscale, 5(19), 8864-8873 (2013-08-15)
The implementation of silicon (Si) in practical lithium ion battery electrodes has been hindered due to its large volume change and consequent structural and interfacial instabilities. Coating nanostructured Si with a second phase (e.g., carbon (C)) represents a very promising
View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service